Fingerprint
Dive into the research topics of 'Docetaxel as monotherapy or combined with ramucirumab or icrucumab in second-line treatment for locally advanced or metastatic urothelial carcinoma: An open-label, three-arm, randomized controlled Phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically